Brazilian President Jair Bolsonaro said Monday that his government would seek emergency use authorization for an Israeli-developed nasal spray against COVID-19 that Prime Minister Benjamin Netanyahu described as a “miracle” treatment.

“EXO-CD24 is a nasal spray developed by the Ichilov Medical Center in Israel, with nearly 100-percent effectiveness — 29 out of 30 — against COVID in serious cases,” Bolsonaro tweeted, two days after speaking on the phone with Netanyahu, who calls the Brazilian far-right leader a “good friend.”

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

“A request to analyze this medication for emergency use will be sent shortly to (federal health regulator) Anvisa,” Bolsonaro wrote.

Ichilov Hospital announced two weeks ago that one of its researchers had carried out Phase One testing — typically the first of three phases of clinical trials — on a nasal spray he developed against respiratory symptoms linked to COVID-19.

The researcher, Nadir Arber, reported he had administered the spray to 30 patients with moderate to severe cases of COVID-19, and that 29 of them had been released from hospital in three to five days.

Read more at Times of Israel.